相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
Robert Snoek et al.
CLINICAL CANCER RESEARCH (2009)
Crosstalk between the Androgen Receptor and beta-Catenin in Castrate-Resistant Prostate Cancer
Gang Wang et al.
CANCER RESEARCH (2008)
Downregulation of IFN-γR in association with loss of Fas function is linked to tumor progression
Dafeng Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Hans Lilja et al.
NATURE REVIEWS CANCER (2008)
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression
Soo Ok Lee et al.
PROSTATE (2007)
Relaxin promotes prostate cancer progression
Shu Feng et al.
CLINICAL CANCER RESEARCH (2007)
Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens
Vanessa C. Thompson et al.
PROSTATE (2006)
The role of the DIF motif of the DnaJ (Hsp40) co-chaperone in the regulation of the DnaK (Hsp70) chaperone cycle
GC Cajo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms leading to the development of hormone-resistant prostate cancer
Susan Kasper et al.
UROLOGIC CLINICS OF NORTH AMERICA (2006)
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism
JL Dai et al.
CANCER RESEARCH (2005)
Mechanisms of the development of androgen independence in prostate cancer
A So et al.
WORLD JOURNAL OF UROLOGY (2005)
Androgen receptor signaling: Mechanism of interleukin-6 inhibition
L Jia et al.
CANCER RESEARCH (2004)
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
P Rocchi et al.
CANCER RESEARCH (2004)
Androgen receptor cross-talk with cell signalling pathways
Z Culig
GROWTH FACTORS (2004)
Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway
SO Lee et al.
PROSTATE (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells
L Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Interleukin-6: minor player or starring role in the development of hormone-refractory prostate cancer?
NM Corcoran et al.
BJU INTERNATIONAL (2003)
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway
H Steiner et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Interleukin-6-and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells
PD Deeble et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
CRBP suppresses breast cancer cell survival and anchorage-independent growth
YS Kuppumbatti et al.
ONCOGENE (2001)
Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype
S Soker et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: Evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts
RJ Stewart et al.
JOURNAL OF UROLOGY (2001)
Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway
H Miyake et al.
ENDOCRINOLOGY (2000)
分享论文
